Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OnabotulinumtoxinA vs Placebo for Masticatory Myofascial Pain Syndrome
NCT07878780Phase 2Not yet recruiting
- Sponsor
- Weill Cornell Medicine
- Start
- Oct 2026
- Primary completion
- Oct 2029
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in myofascial pain syndrome (MPS), sponsored by Weill Cornell Medicine. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
myofascial pain syndrome (MPS)
Beyond the preview
Go deeper on NCT07878780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07878780.